Member access

4-Traders Homepage  >  Shares  >  SHENZHEN STOCK EXCHANGE  >  Beijing SL Pharmaceutical Co Ltd    002038   CNE000001L31

No quotes available
-- CNY   --.--%
08/20 BEIJING SL PHARMACEUTICAL : H1 Net Up 22%
04/28 BEIJING SL PHARMACEUTICAL : SL Pharmaceutical 2013 Net Up 20.04%
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Beijing SL Pharmaceutical
Produces and supplies pharmaceutical products

Beijing SL Pharmaceutical Co. Ltd. engages in the development and marketing gene engineering drugs.

Its products include Li Sheng Su, a recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) injection; Mai Ge Er, a recombinant human Interleukin-11 (rhIL-11) injection; and Xin Ji Er, a recombinant human Ala Interleukin-2 (Ala IL-2) injection.

The company was founded by Ming Bo Xu in December 1994 and is headquartered in Beijing, China.

Number of employees : 637 persons.
Sales per Businesses
20122013Delta
CNY (in Million)%CNY (in Million)%
Biochemical Medicine822.9081.8%981.0284.5% +16.12%
Chemistry Medicine128.9412.8%131.5311.3% +1.97%
Other Service Income55.185.5%35.003% -57.68%
Other--14.231.2%-
Sales per Regions
20122013Delta
CNY (in Million)%CNY (in Million)%
China1,006100%1,161100% +13.33%
Managers
NameAgeSinceTitle
Mingbo Xu, PhD50-Chairman & President
Anjing Lu57-Chairman-Supervisory Board
Wenying Xi51-Chief Financial Officer
Yu Lin Chen69-Director
Xiu Jiang Wen37-Director-Supervisory Board
Qing Jun Ma78-Independent Director
Su Yan Wei, CPA62-Independent Director
Ming Xi Zhang, CPA442007Independent Director
Shujie Liang48-Board Secretary
Yong Bo Wang39-Vice President
Shareholders
NameShares%
Xinxiang State Owned Asset Sup. & Adm. Commssion 96,643,72925.8%
Mingbo Xu, PhD 25,743,5016.86%
China International Fund Management Co., Ltd. 12,095,8893.23%
China Resources SZITIC Trust Co., Ltd. 10,100,0442.69%
E Fund Management Co., Ltd. 8,950,6692.39%
Harvest Fund Management Co., Ltd. 8,661,0372.31%
Bin Wang 5,479,1001.46%
Fortune SG Fund Management Co., Ltd. 5,398,1441.44%
China Universal Asset Management Co., Ltd. 4,932,5851.32%
Penghua Fund Management Co., Ltd. 4,880,2201.30%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation -
Finances -
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
BEIJING SL PHARMA..
HUALAN BIOLOGICAL..
NPS PHARMACEUTICA..
AGIOS PHARMACEUTI..
TONGHUA DONGBAO P..
GENMAB A/S
MANNKIND CORPORAT..
AVANIR PHARMACEUT..
CLOVIS ONCOLOGY I..
RECEPTOS INC
BIOCON LTD
KERYX BIOPHARMACE..
DYAX CORP.
GW PHARMACEUTICAL..
ACORDA THERAPEUTI..
CHINA BIOLOGIC PR..
Sector Biotechnology & Medical Research
Company contact information
Beijing SL Pharmaceutical Co., Ltd.
9 Zhongyuan Road
Bada High Development District
Beijing 100041

Phone : +86.10.8879.9370
Fax : +86.10.8879.5883
Web : www.slpharm.com.cn
© 2014 Factset   
Dynamic quotes  
ON
| OFF